Filing Details
- Accession Number:
- 0001209191-20-007060
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-05 20:21:37
- Reporting Period:
- 2020-02-04
- Accepted Time:
- 2020-02-05 20:21:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1645666 | Kezar Life Sciences Inc. | KZR | Pharmaceutical Preparations (2834) | 473366145 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1744263 | Franklin John Fowler | C/O Kezar Life Sciences, Inc. 4000 Shoreline Court, Suite 300 South San Francisco CA 94080 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-04 | 38,461 | $2.60 | 38,461 | No | 4 | P | Indirect | By Montebello Holdings LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Montebello Holdings LLC |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,750 | Indirect | By Trust |
Common Stock | 343,204 | Direct |
Footnotes
- Shares were purchased in a public offering of the Issuer at a public offering price of $2.60.
- The reporting person is a member of Montebello Holdings LLC. The reporting person disclaims Section 16 beneficial ownership of the securities held by Montebello Holdings LLC, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.